Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion type Assertion NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_head.
- NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion description "[Recent studies are shedding light on the molecular basis of myelodysplasia and how mutations and epimutations can induce and promote this neoplastic process through aberrant transcription factor function (RUNX1, ETV6, TP53), kinase signalling (FLT3, NRAS, KIT, CBL) and epigenetic deregulation (TET2, IDH1/2, DNMT3A, EZH2, ASXL1, SF3B1, U2AF1, SRSF2, ZRSR2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_provenance.
- NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion evidence source_evidence_literature NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_provenance.
- NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion SIO_000772 24903747 NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_provenance.
- NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion wasDerivedFrom befree-20150227 NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_provenance.
- NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_assertion wasGeneratedBy ECO_0000203 NP285096.RAbgDrpuwk3beH8QFx6L1g3gJ3WuRkNS_z3IjnJpLZax4130_provenance.